1.Cardiac Toxicities Associated with Herbal Remedies.
Woo Jin JUNG ; Hyun KIM ; Yong Sung CHA ; Oh Hyun KIM ; Kyoung Chul CHA ; Kang Hyun LEE ; Sung Oh HWANG
Journal of The Korean Society of Clinical Toxicology 2012;10(1):1-7
PURPOSE: Herbal preparations have long been used for medical purposes by traditional cultures, and their use is increasing in modern societies. However, many herbal agents produce specific cardiovascular toxicities in humans. We performed this study in order to investigate the clinical characteristics of the cardiac toxicities associated with herbal remedies. METHODS: We conducted a retrospective study of 45 patients (mean age 57+/-10 years) who presented with cardiotoxicity between January 2007 and May 2011 due to ingestion of herbal remedy substances. Patients were identified as suffering cardiotoxicity if they presented with chest pain, EKG abnormality, and elevation of cardiac enzyme. RESULTS: Of the 45 total cases, 17 included hemodynamic instability (37.8%), 7 with increasing cardiac enzyme (15.6%), 2 with cardiac arrest (4.4%) and one case of mortality (2.2%). The cardiotoxic herb group that demonstrated the worst clinical course was Ranunculaceae. CONCLUSIONS: In our study results, 57.6% of the herbal intoxication patients demonstrated the effects of cardiotoxicity. Thus, we recommend careful monitoring of herbal intoxication patients.
Cardiotoxins
;
Chest Pain
;
Eating
;
Electrocardiography
;
Heart Arrest
;
Hemodynamics
;
Humans
;
Plant Preparations
;
Retrospective Studies
;
Stress, Psychological
2.Cardiovascular aspects of aconitine poisoning.
Woo Shik KIM ; Seong Shik LIM ; Heung Sun KANG ; Chung Whee CHOUE ; Kwon Sam KIM ; Jung Sang SONG ; Jong Hoa BAE
Korean Circulation Journal 2000;30(7):855-860
BACKGROUND AND OBJECTIVES: The Oriental herbal materials known as aconitine have long been used in oriental traditional medicine for their analgesic and antiinflammatory effects. Aconitine and its related alkaloids are known cardiotoxins with no therapeutic role in modern western medicine. We have studied the cardiovascular side effects of intoxication that took place in otherwise healthy individuals after ingestion of herbal decoctions containing aconite alkaloids. MATERIALS AND METHOD: During a six-year interval from 1990 to 1996, 9 cases of accidental herb-induced aconitine intoxication were managed in Kyung Hee university medical center. Hospital records were reviewed in detail. RESULTS: All patients developed symptoms of aconitine toxicity within 4 hours of herb ingestion. The frequency of the order in cardinal symptoms of acute aconitine poisoning was nausea or vomiting, irritability, chest discomfort, dizziness, etc. Nine patients developed arrhythmias, including multifocal APC with aberrancy, multifocal VPC, ventricular tachycardia, etc. Administration of isotonic saline, dopamine, atropine and lidocaine with supportive cares brought clinical recovery and disappearance of arrhythmias in most cases within several hours. However, one case of acute aconitine poisoning had been dead of cardiac arrest due to ventricular fibrillation. CONCLUSION: Aconitine and its related alkaloids can cause toxic effects and even fatal poisoning. These cases point to the need for strict surveillance of herbal substances with low safety margins.
Academic Medical Centers
;
Aconitine*
;
Aconitum
;
Alkaloids
;
Arrhythmias, Cardiac
;
Atropine
;
Cardiotoxins
;
Dizziness
;
Dopamine
;
Eating
;
Heart Arrest
;
Hospital Records
;
Humans
;
Lidocaine
;
Medicine, East Asian Traditional
;
Nausea
;
Poisoning*
;
Tachycardia, Ventricular
;
Thorax
;
Ventricular Fibrillation
;
Vomiting
3.Value of cardiac troponin I measurement in prediction of anthracycline-induced cardiotoxicity in breast cancer patients.
Wei-bin HUANG ; Guang-yu YAO ; Min-feng LIU ; Rui-ting CHEN ; Lu-jia CHEN ; Jian-yu DONG ; Fan GU ; Zhao-ze GUO ; Chang-sheng YE
Journal of Southern Medical University 2011;31(6):1047-1050
OBJECTIVETo evaluate the value of cardiac troponin I (CTnI) measurement in predicting anthracycline-induced cardiotoxicity in patients with breast cancer.
METHODSThis study was conducted among 186 breast cancer patients receiving anthracycline-based chemotherapy. Serum cTnI concentrations before and after each cycle of the chemotherapy and the left ventricular ejection fraction (LVEF) before and at the 2nd, 4th and 6th months of the treatment were recorded. According to serum cTnI concentration, the patients were divided into CTnI+ group (with serum CTnI concentration of no less than 0.1 ng/ml, n=60) and CTnI- (<0.1 ng/ml) group (n=126).
RESULTSNo patients in this series experienced cardiac heart failure (CHF). The number of patients with a LVEF reduction by over 10% from the baseline was 16 (26.7%) in CTnI+ group, as compared to 7 (5.6%) in CTnI- group, showing a significant difference between the two groups (P<0.01).
CONCLUSIONCTnI can be a useful marker for early prediction of anthracycline-induced cardiotoxicity in patients with breast cancer.
Adult ; Aged ; Anthracyclines ; adverse effects ; therapeutic use ; Antibiotics, Antineoplastic ; therapeutic use ; Biomarkers ; blood ; Breast Neoplasms ; drug therapy ; Cardiotoxins ; adverse effects ; Female ; Humans ; Middle Aged ; Myocardium ; metabolism ; Troponin I ; blood ; Young Adult